In addition, qRT-PCR and western blot results showed that GRP78-exos treatment dramatically upregulated the expression of stem cell markers CD133, CD44, and ALDH1A1 in CRC cells (Fig. 2I, J). This evidence concerns the gene PROM1 and colorectal carcinoma.